Biodesix Reports 65% Growth In Lung Diagnostic Test Volume In Q4

Biodesix Inc. reported strong Q4 performance, with significant revenue growth.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.